Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F20%3A10406380" target="_blank" >RIV/00216208:11150/20:10406380 - isvavai.cz</a>

Alternative codes found

RIV/00216224:14110/20:00115331 RIV/65269705:_____/20:00072322 RIV/00179906:_____/20:10406380 RIV/00098892:_____/20:N0000038 RIV/00843989:_____/20:E0108265

Result on the web

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=W.c6v3SEa8" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=W.c6v3SEa8</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/10428194.2019.1672054" target="_blank" >10.1080/10428194.2019.1672054</a>

Result language

angličtina

Original language name

Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study

Original language description

The aim of our study was to prospectively monitor and analyze lipid metabolism abnormalities in de novo CML patients treated with NILO at the start and during the first year of tyrosine kinase inhibitors therapy and to compare the results with patients receiving IMA. We evaluated the association of these laboratory changes with the risk of future CV events, CV risk dynamics, and use of statins during tyrosine kinase inhibitors administration based on the European Society of Cardiology guidelines.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30205 - Hematology

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2020

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Leukemia &amp; Lymphoma

ISSN

1042-8194

e-ISSN

—

Volume of the periodical

61

Issue of the periodical within the volume

2

Country of publishing house

GB - UNITED KINGDOM

Number of pages

3

Pages from-to

494-496

UT code for WoS article

000489439400001

EID of the result in the Scopus database

2-s2.0-85074026728